Pathological and Therapeutical Implications of Macromolecule Passage through the Tight Junction

[1]  A. Fasano,et al.  Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease , 2000, The Lancet.

[2]  A. Leone-Bay,et al.  The Development of Delivery Agents that Facilitate the Oral Absorption of Macromolecular Drugs , 2000, Medicinal research reviews.

[3]  H. Junginger,et al.  Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[4]  H. R. Zielke,et al.  Affinity Purification and Partial Characterization of the Zonulin/Zonula Occludens Toxin (Zot) Receptor from Human Brain , 2000, Journal of neurochemistry.

[5]  P. Cappuccinelli,et al.  Expression of Vibrio cholerae zonula occludens toxin and analysis of its subcellular localization. , 1999, Microbial pathogenesis.

[6]  L. Greco,et al.  Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. , 1999, Gastroenterology.

[7]  V. Dodane,et al.  Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.

[8]  D. Iafusco,et al.  Altered intestinal permeability to mannitol in diabetes mellitus type I. , 1999, Journal of pediatric gastroenterology and nutrition.

[9]  M. Marinaro,et al.  Zonula Occludens Toxin Is a Powerful Mucosal Adjuvant for Intranasally Delivered Antigens , 1999, Infection and Immunity.

[10]  J. Schulzke,et al.  Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. , 1999, Gastroenterology.

[11]  D. Jewell,et al.  Coeliac disease in primary care: case finding study , 1999, BMJ.

[12]  W. Maksymowych,et al.  Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives. , 1999, The Journal of rheumatology.

[13]  A. Fasano.  Novel approaches for oral delivery of macromolecules. , 1998, Journal of pharmaceutical sciences.

[14]  A. Fasano,et al.  Innovative strategies for the oral delivery of drugs and peptides. , 1998, Trends in biotechnology.

[15]  J. Schulzke,et al.  Epithelial Tight Junction Structure in the Jejunum of Children with Acute and Treated Celiac Sprue , 1998, Pediatric Research.

[16]  J. Partanen,et al.  Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. , 1998, Scandinavian journal of gastroenterology.

[17]  L. Prokai.  Peptide drug delivery into the central nervous system. , 1998, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[18]  A. Fasano,et al.  Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. , 1997, The Journal of clinical investigation.

[19]  A. Fasano,et al.  The enterotoxic effect of zonula occludens toxin on rabbit small intestine involves the paracellular pathway. , 1997, Gastroenterology.

[20]  J Yu,et al.  Pulmonary drug delivery: physiologic and mechanistic aspects. , 1997, Critical reviews in therapeutic drug carrier systems.

[21]  D. Begley,et al.  The Blood‐brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System , 1996, The Journal of pharmacy and pharmacology.

[22]  T. Kovács,et al.  Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. , 1996, American journal of nephrology.

[23]  Y. Chien,et al.  Systemic delivery of peptides and proteins across absorptive mucosae. , 1996, Critical reviews in therapeutic drug carrier systems.

[24]  C. Fiorentini,et al.  Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. , 1995, The Journal of clinical investigation.

[25]  C. Catassi,et al.  High prevalence of undiagnosed coeliae disease in 5280 Italian students screened by antigliadin antibodies , 1995, Acta paediatrica.

[26]  M. Mäki,et al.  Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus. , 1995, Gut.

[27]  J. Meddings,et al.  CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability. , 1995, Gastroenterology.

[28]  J. Cantero-Hinojosa,et al.  Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. , 1994, British journal of rheumatology.

[29]  P. Artursson,et al.  Mechanisms of absorption enhancement and tight junction regulation , 1994 .

[30]  S. Emancipator.  IgA nephropathy: morphologic expression and pathogenesis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[32]  L. Pilarski,et al.  Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease. , 1993, Gut.

[33]  E. Thorsby,et al.  HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. , 1993, Gastroenterology.

[34]  E. Isolauri,et al.  Diet during Rotavirus Enteritis Affects Jejunal Permeability to Macromolecules in Suckling Rats , 1993, Pediatric Research.

[35]  M. Meignan,et al.  Mucosal Immunity in Primary Glomerulonephritis , 1993 .

[36]  N. Weiner,et al.  Topical delivery of liposomally encapsulated gamma-interferon. , 1992, Antiviral research.

[37]  S. Citi.  Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells , 1992, The Journal of cell biology.

[38]  J. Kaper,et al.  Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae , 1992, Infection and immunity.

[39]  J. Kaper,et al.  Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. De Vos,et al.  Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease. , 1991, Journal of Rheumatology.

[41]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[42]  U. Kompella,et al.  Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. , 1991, Critical reviews in therapeutic drug carrier systems.

[43]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[44]  R. Coppo,et al.  Effects of a gluten-free diet in primary IgA nephropathy. , 1990, Clinical nephrology.

[45]  P. Krajči,et al.  Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. , 1989, Gastroenterology.

[46]  J. Madara,et al.  Loosening tight junctions. Lessons from the intestine. , 1989, The Journal of clinical investigation.

[47]  H. Oksa,et al.  High frequency of coeliac disease in adult patients with type-I diabetes. , 1989, Scandinavian journal of gastroenterology.

[48]  D. Shasby,et al.  Oxidants and conductance of cultured epithelial cell monolayers: inositol phospholipid hydrolysis. , 1988, The American journal of physiology.

[49]  J. Madara,et al.  The selective and superoxide-independent disruption of intestinal epithelial tight junctions during leukocyte transmigration. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[50]  J. Nagy,et al.  Antibodies to dietary antigens in IgA nephropathy. , 1988, Clinical nephrology.

[51]  J. Davin,et al.  Increased Intestinal Permeability to (51 Cr) EDTA Is Correlated with IgA Immune Complex‐Plasma Levels in Children with IgA‐Associated Nephropathies , 1988, Acta paediatrica Scandinavica.

[52]  J. Feehally.  Immune mechanisms in glomerular IgA deposition. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[53]  M. A. Saper,et al.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.

[54]  M. De Vos,et al.  Histopathology of intestinal inflammation related to reactive arthritis. , 1987, Gut.

[55]  S. Ukabam,et al.  Intestinal Permeability in Diabetic Diarrhoea , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[56]  J. Rotter,et al.  Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. , 1986, Annals of internal medicine.

[57]  G. Conyers,et al.  The effect of neutrophil migration on epithelial permeability , 1986, The Journal of cell biology.

[58]  A. Levi,et al.  Intestinal permeability: clinical correlates. , 1986, Digestive diseases.

[59]  P. Brooks,et al.  Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. , 1985, The Journal of rheumatology.

[60]  A. Hand,et al.  Alteration of tight junctional permeability in the rat parotid gland after isoproterenol stimulation , 1984, The Journal of cell biology.

[61]  L. Schiller,et al.  Disorders of gastrointestinal motility associated with diabetes mellitus. , 1983, Annals of internal medicine.

[62]  J. Madara,et al.  Structural abnormalities of jejunal epithelial cell membranes in celiac sprue. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[63]  N. Asp,et al.  Small intestinal dipeptidases and disaccharidases in experimental uremia in rats. , 1980, Nephron.

[64]  C. Sardet,et al.  The surface epithelium of teleostean fish gills. Cellular and junctional adaptations of the chloride cell in relation to salt adaptation , 1979, The Journal of cell biology.

[65]  T. Magnuson,et al.  Relationship between intercellular permeability and junction organization in the preimplantation mouse embryo. , 1978, Developmental biology.

[66]  E. Schneeberger,et al.  Development of intercellular junctions in the pulmonary epithelium of the foetal lamb. , 1978, Journal of cell science.

[67]  Diamond Jm,et al.  Twenty-first Bowditch lecture. The epithelial junction: bridge, gate, and fence. , 1977 .

[68]  N. Gilula,et al.  The Sertoli cell occluding junctions and gap junctions in mature and developing mammalian testis. , 1976, Developmental biology.

[69]  S. Brown,et al.  Cell junctions in development, with particular reference to the neural tube. , 1976, Cold Spring Harbor symposia on quantitative biology.

[70]  A. Mcnair,et al.  Disaccharidase activity in chronic renal failure. , 2009, Acta medica Scandinavica.